KYMAB

kymab-logo

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics with a focus on immune-mediated diseases and immuno-oncology using its proprietary, integrated platforms collectively called IntelliSelectยฎ. Kymabโ€™s IntelliSelect Transgenic platforms contain a full diversity of human antibodies, making them the most comprehensive antibody platforms available. The company was founded in 2010 and is based in Cambridge, the United Kingdom.

#SimilarOrganizations #People #Financial #Website #More

KYMAB

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2010-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.kymab.com

Total Employee:
101+

Status:
Active

Contact:
44 1223 833301

Email Addresses:
[email protected]

Total Funding:
229.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Mobile Non Scaleable Content


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

curevac-logo

CureVac

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

nautilus-biotech-logo

Nautilus Biotech

Nautilus Biotech is a clinical-stage biopharmaceutical company focused on developing therapeutic proteins.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.


Current Advisors List

david-chiswell_image

David Chiswell Chairman @ Kymab
Board_member
2012-09-01

Current Employees Featured

jasper-clube_image

Jasper Clube
Jasper Clube Senior Vice President, Intellectual Property & Chief Patent Council @ Kymab
Senior Vice President, Intellectual Property & Chief Patent Council
2010-08-01

brandon-lewis_image

Brandon Lewis
Brandon Lewis Head of Corporate Strategy and Investor Relations @ Kymab
Head of Corporate Strategy and Investor Relations

anne-hyland_image

Anne Hyland
Anne Hyland Chief Financial Officer & Company Secretary @ Kymab
Chief Financial Officer & Company Secretary

nigel-clark_image

Nigel Clark
Nigel Clark Senior Vice President, Business Development @ Kymab
Senior Vice President, Business Development

not_available_image

Paulette Alexander
Paulette Alexander Office Manager @ Kymab
Office Manager
2010-04-01

allan-bradley_image

Allan Bradley
Allan Bradley Chief Scientific Officer @ Kymab
Chief Scientific Officer
2010-07-01

Founder


allan-bradley_image

Allan Bradley

glenn-friedrich_image

Glenn Friedrich

Investors List

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Grant - Kymab

malin-corporation-plc_image

Malin Corporation

Malin Corporation investment in Series C - Kymab

woodford-investment-management_image

Woodford Investment Management

Woodford Investment Management investment in Series C - Kymab

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series C - Kymab

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Series C - Kymab

hepalink_image

Hepalink

Hepalink investment in Series C - Kymab

ori-capital_image

ORI Capital

ORI Capital investment in Series C - Kymab

malin-corporation-plc_image

Malin Corporation

Malin Corporation investment in Series B - Kymab

woodford-investment-management_image

Woodford Investment Management

Woodford Investment Management investment in Series B - Kymab

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series B - Kymab

Official Site Inspections

http://www.kymab.com Semrush global rank: 3.64 M Semrush visits lastest month: 3.91 K

  • Host name: 178.62.11.133
  • IP address: 178.62.11.133
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...

More informations about "Kymab" on Search Engine